Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Dopamine, neuroleptics and reinforced behavior.

Ettenberg A.

Neurosci Biobehav Rev. 1989 Summer-Fall;13(2-3):105-11. Review.

PMID:
2573021
2.
3.
4.

Dopamine receptor antagonists reverse amphetamine-induced behavioral alteration on a differential reinforcement for low-rate (DRL) operant task in the rat.

Cheng RK, Liao RM.

Chin J Physiol. 2007 Apr 30;50(2):77-88. Erratum in: Chin J Physiol. 2007 Jun 30;50(3):149.

PMID:
17608145
5.

Attenuation of sucrose reinforcement in dopamine D1 receptor deficient mice.

El-Ghundi M, O'Dowd BF, Erclik M, George SR.

Eur J Neurosci. 2003 Feb;17(4):851-62.

PMID:
12603275
6.

Behavioral functions of nucleus accumbens dopamine: empirical and conceptual problems with the anhedonia hypothesis.

Salamone JD, Cousins MS, Snyder BJ.

Neurosci Biobehav Rev. 1997 May;21(3):341-59. Review.

PMID:
9168269
7.

A partial reinforcement extinction effect in water-reinforced rats intermittently treated with haloperidol.

Ettenberg A, Camp CH.

Pharmacol Biochem Behav. 1986 Dec;25(6):1231-5.

PMID:
3809225
8.

The neurotensin receptor agonist NT69L suppresses sucrose-reinforced operant behavior in the rat.

Boules M, Iversen I, Oliveros A, Shaw A, Williams K, Robinson J, Fredrickson P, Richelson E.

Brain Res. 2007 Jan 5;1127(1):90-8. Epub 2006 Nov 17.

PMID:
17113052
9.

Dopamine in the orbitofrontal cortex regulates operant responding under a progressive ratio of reinforcement in rats.

Cetin T, Freudenberg F, Füchtemeier M, Koch M.

Neurosci Lett. 2004 Nov 11;370(2-3):114-7.

PMID:
15488305
10.
12.

L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests.

Bristow LJ, Collinson N, Cook GP, Curtis N, Freedman SB, Kulagowski JJ, Leeson PD, Patel S, Ragan CI, Ridgill M, Saywell KL, Tricklebank MD.

J Pharmacol Exp Ther. 1997 Dec;283(3):1256-63.

13.

Behavioral effects of neurotensin: operant responding and assessment of 'anhedonia'.

Rossitch E Jr, King RA, Luttinger D, Nemeroff CB.

Eur J Pharmacol. 1989 Apr 12;163(1):119-22.

PMID:
2744087
14.
15.

The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one affects dopamine-mediated behavior in rodents.

Khisti RT, Deshpande LS, Chopde CT.

Psychopharmacology (Berl). 2002 May;161(2):120-8. Epub 2002 Mar 14.

PMID:
11981591
16.
17.

Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.

Korff S, Harvey BH.

Psychiatr Clin North Am. 2006 Jun;29(2):371-90. Review.

PMID:
16650714
18.

Genetic differences in NMDA and D1 receptor levels, and operant responding for food and morphine in Lewis and Fischer 344 rats.

Martín S, Lyupina Y, Crespo JA, González B, García-Lecumberri C, Ambrosio E.

Brain Res. 2003 May 30;973(2):205-13.

PMID:
12738064
19.

Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists.

Caine SB, Negus SS, Mello NK, Patel S, Bristow L, Kulagowski J, Vallone D, Saiardi A, Borrelli E.

J Neurosci. 2002 Apr 1;22(7):2977-88.

Supplemental Content

Support Center